Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Desitin Arzneimittel GmbH

Success in CNS

The company in detail

Summary

Desitin Pharmaceuticals, founded in 1919 in Berlin and located since 1945 in Hamburg Fuhlsbüttel, is an independent family-owned pharmaceutical company. The main focus of the company's efforts is in the area of research and development. In collaboration with other future-oriented enterprises, for example, in the area of biotechnology, the company will continue to develop and produce successful products for the treatment of central nervous system diseases. The company cooperate closely with the treating physicians to promote long-term therapeutic success in neurological-psychiatric disorders.

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Deals

To view this information, you must subscribe to Partneringtools.
Partnering consultation free of charge
Clinical Outsourcing World
Profile your company today
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us